MedTrace Logo

"Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"

NCT00881543 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2012-05-28

No results posted yet for this study

Summary

The purpose of this study is to demonstrate the secretion of glucose, insulin, glucagon, C-peptide and lipid profile after isocaloric diets with different nutritional compounds (fat, protein and carbohydrate food) in drug näive tipo 2 patients.

Conditions

  • Diabetes Type 2

Interventions

DRUG

Dipeptidyl Peptidase IV inhibitors

Dosage 100 mg each day, once a day, 2 months

Sponsors & Collaborators

  • University of Sao Paulo

    collaborator OTHER

  • University of Sao Paulo General Hospital

    lead OTHER

Principal Investigators

  • Cristina S Oliveira, Pos Grad · Sao Paulo General Hospital

  • Bernardo L Wajchenberg, PhD · Sao Paulo General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2010-06-30
Completion
2011-10-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00881543 on ClinicalTrials.gov